{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-questionFirstAnswered.=2019-07-02T16%3A12%3A14.213Z&hansardHeading=Lung+Diseases", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-questionFirstAnswered.=2019-07-02T16%3A12%3A14.213Z&hansardHeading=Lung+Diseases", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-questionFirstAnswered.=2019-07-02T16%3A12%3A14.213Z&_metadata=all&hansardHeading=Lung+Diseases", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&min-questionFirstAnswered.=2019-07-02T16%3A12%3A14.213Z&hansardHeading=Lung+Diseases", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-questionFirstAnswered.=2019-07-02T16%3A12%3A14.213Z&hansardHeading=Lung+Diseases", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-questionFirstAnswered.=2019-07-02T16%3A12%3A14.213Z&hansardHeading=Lung+Diseases", "items" : [{"_about" : "http://data.parliament.uk/resources/1656911", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1656911/answer", "answerText" : {"_value" : "<p>The NHS Long Term Plan made a commitment to tackling health inequalities and earlier intervention to detect and treat respiratory disease. NHS England has set out Core20PLUS5, a national approach to reduce healthcare inequalities at both national and system level. The approach defines a target population (the \u2018Core20PLUS\u2019) and identifies \u20185\u2019 focus clinical areas requiring accelerated improvement.<\/p><p>The approach will include a focus on Chronic Obstructive Pulmonary Disease driving up uptake of COVID-19, flu and pneumonia vaccines to reduce exacerbations of the disease and to reduce emergency hospital admissions due to those exacerbations, as well as smoking cessation given the strong social gradient in smoking rates that contributes to inequalities in respiratory disease and other major causes of death.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
        }
        , "answeringMemberConstituency" : {"_value" : "Colchester"}
        , "answeringMemberPrinted" : {"_value" : "Will Quince"}
        , "dateOfAnswer" : {"_value" : "2023-09-07", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-09-07T15:15:02.903Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-09-01", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Lung Diseases"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to reduce respiratory health inequalities.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4488", "label" : {"_value" : "Biography information for Martyn Day"}
      }
      , "tablingMemberConstituency" : {"_value" : "Linlithgow and East Falkirk"}
      , "tablingMemberPrinted" : [{"_value" : "Martyn Day"}
      ], "uin" : "196576"}
    , {"_about" : "http://data.parliament.uk/resources/1642100", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1642100/answer", "answerText" : {"_value" : "<p>NHS England has established a national respiratory programme to develop a clear approach, in partnership with its partners, to improve outcomes for people with respiratory disease and meet the Long Term Plan ambitions. In addition, the Major Conditions Strategy will cover treatment and prevention for chronic respiratory diseases and seeking input, through our Call for Evidence, from stakeholders, citizens and the NHS to identify actions that will have the most impact.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4527", "label" : {"_value" : "Biography information for Helen Whately"}
        }
        , "answeringMemberConstituency" : {"_value" : "Faversham and Mid Kent"}
        , "answeringMemberPrinted" : {"_value" : "Helen Whately"}
        , "dateOfAnswer" : {"_value" : "2023-06-14", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-06-14T16:30:09.8Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-06-06", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Lung Diseases"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help reduce lung and respiratory-related deaths in the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
      }
      , "tablingMemberConstituency" : {"_value" : "Strangford"}
      , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
      ], "uin" : "187976"}
    , {"_about" : "http://data.parliament.uk/resources/1608333", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1608333/answer", "answerText" : {"_value" : "<p>Work on the Major Conditions Strategy is ongoing and we are committed to ensuring that the Strategy\u2019s approach is rooted in the best understanding of the evidence to tackle the major conditions which contribute to the burden of disease in England, including respiratory conditions. This includes seeking the views of and working closely with stakeholders, citizens and the National Health Service.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4527", "label" : {"_value" : "Biography information for Helen Whately"}
        }
        , "answeringMemberConstituency" : {"_value" : "Faversham and Mid Kent"}
        , "answeringMemberPrinted" : {"_value" : "Helen Whately"}
        , "dateOfAnswer" : {"_value" : "2023-04-03", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "175616"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-04-03T10:57:00.823Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-03-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Lung Diseases"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he is taking steps to ensure that (a) asthma, (b) chronic obstructive pulmonary disease and (c) other respiratory health diseases are priorities of the forthcoming Major Conditions and Disease Strategy.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4386", "label" : {"_value" : "Biography information for Margaret Ferrier"}
      }
      , "tablingMemberConstituency" : {"_value" : "Rutherglen and Hamilton West"}
      , "tablingMemberPrinted" : [{"_value" : "Margaret Ferrier"}
      ], "uin" : "175614"}
    , {"_about" : "http://data.parliament.uk/resources/1608335", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1608335/answer", "answerText" : {"_value" : "<p>General Practices (GPs) are required to provide services, termed \u2018essential services\u2019, to meet the reasonable needs of their registered and temporary patients. This includes providing consultations, referrals and ongoing treatment and care as necessary and appropriate.<\/p><p>Some GP practices may opt into providing additional services over and above this. The Quality and Outcomes Framework (QOF) is a voluntary reward and incentive scheme to help improve the quality of care across GPs. This incentivises practices to undertake specific activities in order to improve prevention and long-term condition management, including tackling respiratory health conditions. In the 2023/24 GP contract, nine QOF indicators (16%) will target tackling respiratory health conditions.<\/p><p>Vaccination against COVID-19 and flu can also support a reduction in cases of respiratory virus during the winter, both amongst the general public and the healthcare workforce. Over 17.4 million doses of an autumn COVID-19 booster were delivered in England over winter 2022/23 and as of 28 February, more than 21.1 million people in England have had their flu jabs.<\/p><p>The vaccine programmes provide necessary protection to those at higher risk of severe illness and are keeping more people out of hospital. The Government encourages all of those who are eligible for vaccinations to come forward.<\/p><p>The Department continues to work with tripartite partners to deliver improvements to vaccinations, including acquiring data to allow for timely and targeted action, and to identify and provide advice on reducing disparities in vaccination coverage.<\/p><p>The tripartite is committed to improving childhood and adult immunisation programmes, driving maximum uptake, and working hard towards re-gaining the United Kingdom\u2019s measles elimination status, and sustaining our rubella and polio status.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4679", "label" : {"_value" : "Biography information for Neil O'Brien"}
        }
        , "answeringMemberConstituency" : {"_value" : "Harborough"}
        , "answeringMemberPrinted" : {"_value" : "Neil O'Brien"}
        , "dateOfAnswer" : {"_value" : "2023-04-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-04-04T13:37:26.63Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-03-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Lung Diseases"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent steps (a) his Department and (b) NHS England have taken to tackle increases in respiratory health conditions in the context of recent changes to GP contracts.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4386", "label" : {"_value" : "Biography information for Margaret Ferrier"}
      }
      , "tablingMemberConstituency" : {"_value" : "Rutherglen and Hamilton West"}
      , "tablingMemberPrinted" : [{"_value" : "Margaret Ferrier"}
      ], "uin" : "175615"}
    , {"_about" : "http://data.parliament.uk/resources/1467593", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1467593/answer", "answerText" : {"_value" : "<p>No specific estimate has been made as this information is not collected in the format requested. However, data from the Quality and Outcomes Framework in 2020/21 shows the prevalence of asthma was 6.38% and 1.38% for chronic obstructive pulmonary disease.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4680", "label" : {"_value" : "Biography information for Gillian Keegan"}
        }
        , "answeringMemberConstituency" : {"_value" : "Chichester"}
        , "answeringMemberPrinted" : {"_value" : "Gillian Keegan"}
        , "dateOfAnswer" : {"_value" : "2022-06-20", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-06-20T14:10:06.437Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-06-06", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Lung Diseases"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people living with lung disease as of 6 June 2022.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
      }
      , "tablingMemberConstituency" : {"_value" : "Strangford"}
      , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
      ], "uin" : "13131"}
    , {"_about" : "http://data.parliament.uk/resources/1416317", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1416317/answer", "answerText" : {"_value" : "<p>The information requested for the number of diagnoses and deaths in England due to pulmonary fibrosis is not held. The information requested for Wales, Scotland and Northern Ireland is not collected as this is a devolved matter.<\/p><p>The National Institute of Health and Care Excellence recently undertook a single technology appraisal of nintedanib, an anti-fibrotic drug for use in patients with many different types of progressive lung fibrosis. The drug is being commissioned by NHS England and NHS Improvement and will be available from 17 February 2022. It is expected it will allow treatment for fibrosis to be administered to a wider group of patients and prolong the lives of many. NHS England and NHS Improvement have amended the dashboard overseeing the performance of specialist interstitial lung disease centres in England. This is intended to deliver improved care for patients with pulmonary fibrosis, focussing on patient outcomes, involvement in research trials and reducing waits in services. The National Institute for Health Research (NIHR) awarded £696,932 for research into pulmonary fibrosis in 2020/21. Currently, the NIHR supports 122 studies into pulmonary fibrosis.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4680", "label" : {"_value" : "Biography information for Gillian Keegan"}
        }
        , "answeringMemberConstituency" : {"_value" : "Chichester"}
        , "answeringMemberPrinted" : {"_value" : "Gillian Keegan"}
        , "dateOfAnswer" : {"_value" : "2022-02-08", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "111777"}
        , {"_value" : "111778"}
        , {"_value" : "111779"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-02-08T15:38:52.39Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-01-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Lung Diseases"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many people have been diagnosed with pulmonary fibrosis in each year from 2010-11 to 2020-21 in (a) England, (b) Wales, (c) Scotland and (d) Northern Ireland.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4873", "label" : {"_value" : "Biography information for Rachel Hopkins"}
      }
      , "tablingMemberConstituency" : {"_value" : "Luton South"}
      , "tablingMemberPrinted" : [{"_value" : "Rachel Hopkins"}
      ], "uin" : "111776"}
    , {"_about" : "http://data.parliament.uk/resources/1416318", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1416318/answer", "answerText" : {"_value" : "<p>The information requested for the number of diagnoses and deaths in England due to pulmonary fibrosis is not held. The information requested for Wales, Scotland and Northern Ireland is not collected as this is a devolved matter.<\/p><p>The National Institute of Health and Care Excellence recently undertook a single technology appraisal of nintedanib, an anti-fibrotic drug for use in patients with many different types of progressive lung fibrosis. The drug is being commissioned by NHS England and NHS Improvement and will be available from 17 February 2022. It is expected it will allow treatment for fibrosis to be administered to a wider group of patients and prolong the lives of many. NHS England and NHS Improvement have amended the dashboard overseeing the performance of specialist interstitial lung disease centres in England. This is intended to deliver improved care for patients with pulmonary fibrosis, focussing on patient outcomes, involvement in research trials and reducing waits in services. The National Institute for Health Research (NIHR) awarded £696,932 for research into pulmonary fibrosis in 2020/21. Currently, the NIHR supports 122 studies into pulmonary fibrosis.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4680", "label" : {"_value" : "Biography information for Gillian Keegan"}
        }
        , "answeringMemberConstituency" : {"_value" : "Chichester"}
        , "answeringMemberPrinted" : {"_value" : "Gillian Keegan"}
        , "dateOfAnswer" : {"_value" : "2022-02-08", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "111776"}
        , {"_value" : "111778"}
        , {"_value" : "111779"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-02-08T15:38:52.437Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-01-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Lung Diseases"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve (a) treatment and (b) support for people living with pulmonary fibrosis.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4873", "label" : {"_value" : "Biography information for Rachel Hopkins"}
      }
      , "tablingMemberConstituency" : {"_value" : "Luton South"}
      , "tablingMemberPrinted" : [{"_value" : "Rachel Hopkins"}
      ], "uin" : "111777"}
    , {"_about" : "http://data.parliament.uk/resources/1330035", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1330035/answer", "answerText" : {"_value" : "<p>The data is not available in the format requested.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
        }
        , "answeringMemberConstituency" : {"_value" : "Charnwood"}
        , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        , "dateOfAnswer" : {"_value" : "2021-06-16", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-06-16T12:46:13.763Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-06-07", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Lung Diseases"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what is the median time to a first appointment with a specialist respiratory consultant when a serious lung condition is suspected, for each hospital Trust in England, for each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1583", "label" : {"_value" : "Biography information for Ms Lyn Brown"}
      }
      , "tablingMemberConstituency" : {"_value" : "West Ham"}
      , "tablingMemberPrinted" : [{"_value" : "Ms Lyn Brown"}
      ], "uin" : "11514"}
    , {"_about" : "http://data.parliament.uk/resources/1330036", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1330036/answer", "answerText" : {"_value" : "<p>The data is not available in the format requested.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
        }
        , "answeringMemberConstituency" : {"_value" : "Charnwood"}
        , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        , "dateOfAnswer" : {"_value" : "2021-06-16", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-06-16T12:47:44.937Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-06-07", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Lung Diseases"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what is the median time to a first diagnostic a) x-ray, b) CT scan, and c) spirometry test, where a serious lung condition is suspected, for each hospital Trust in England, for each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1583", "label" : {"_value" : "Biography information for Ms Lyn Brown"}
      }
      , "tablingMemberConstituency" : {"_value" : "West Ham"}
      , "tablingMemberPrinted" : [{"_value" : "Ms Lyn Brown"}
      ], "uin" : "11515"}
    , {"_about" : "http://data.parliament.uk/resources/1330037", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1330037/answer", "answerText" : {"_value" : "<p>The information is not collected in the format requested.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
        , "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
        , "dateOfAnswer" : {"_value" : "2021-06-21", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-06-21T10:36:13.193Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-06-07", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Lung Diseases"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what is the median time to a diagnosis of Pulmonary Fibrosis, from first presentation to a GP with respiratory symptoms, for each hospital Trust in England, for each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1583", "label" : {"_value" : "Biography information for Ms Lyn Brown"}
      }
      , "tablingMemberConstituency" : {"_value" : "West Ham"}
      , "tablingMemberPrinted" : [{"_value" : "Ms Lyn Brown"}
      ], "uin" : "11516"}
    ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&min-questionFirstAnswered.=2019-07-02T16%3A12%3A14.213Z&hansardHeading=Lung+Diseases", "page" : 0, "startIndex" : 1, "totalResults" : 18, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}